Repository logo
 
Publication

Association between COVID-19 and the incidence of type 1 diabetes in Portugal – a registry study

dc.contributor.authorAndersen, Morten Bjerregaard
dc.contributor.authorSilva, Jessica Da
dc.contributor.authorDiogo,. Rui
dc.contributor.authorClaro, Ana Raquel
dc.contributor.authorFerro, Inês
dc.contributor.authorRomana, Andreia
dc.contributor.authorRocha, Patrícia
dc.contributor.authorSá, Beatriz
dc.contributor.authorLobarinhas, Goreti
dc.contributor.authorRolim, Sara
dc.contributor.authorJuhl, Claus Bogh
dc.contributor.authorHøjlund, Kurt
dc.contributor.authorFernandes, Isabel
dc.contributor.authorAntunes, Sónia
dc.contributor.authorCalha, Maria Manuela Félix
dc.contributor.authorGama, Guida
dc.contributor.authorAmálio, Sofia
dc.contributor.authorFigueiras, Mariana
dc.contributor.authorSilva, Teresa
dc.contributor.authorRosado, Margarida
dc.contributor.authorFerrão, Estela
dc.contributor.authorArez, Luísa
dc.contributor.authorBaptista, Ana
dc.contributor.authorFerreira, Adriana Martins
dc.contributor.authorAlba, Diana
dc.contributor.authorGodinho, Carlos
dc.contributor.authorLeite, Ana Luísa
dc.contributor.authorLopes, Maria de Lurdes Afonso
dc.contributor.authorSampaio, Maria Lurdes
dc.contributor.authorCaetano, Joana Serra
dc.contributor.authorCarvalho, Eugénia
dc.date.accessioned2024-12-11T11:23:42Z
dc.date.available2024-12-11T11:23:42Z
dc.date.issued2024-08-09
dc.description.abstractBackground: Viral respiratory infections may precipitate type 1 diabetes (T1D). A possible association between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, and the incidence of T1D is being determined. This study was carried out using Portuguese registries, aiming at examining temporal trends between COVID-19 and T1D.MethodsHospital data, comparing the incidence before and during the COVID-19 pandemic, from children and young adults diagnosed with new-onset T1D, was acquired beginning in 2017 and until the end of 2022. Data was obtained from nine different Portuguese hospital units. The impact of the COVID-19 pandemic, beginning in March 2020, was assessed comparing the annual numbers of new-onset T1D cases. The annual median levels of glucose, glycated hemoglobin (HbA1c) and fasting C-peptide at T1D diagnosis were compared. The annual number of diabetic ketoacidosis (DKA) episodes among new T1D cases was also assessed at two centers.ResultsIn total, data from 574 newly diagnosed T1D patients was analyzed, including 530 (92.3%) children. The mean ages for child and adult patients were 9.1 (SD 4.4) and 32.8 (SD 13.6) years, respectively. 57.8% (331/573) were male, one patient had unknown sex. The overall median (25-75 percentiles) levels of glucose, HbA1c and fasting C-peptide at diagnosis were 454 mg/dL (356-568), 11.8% (10.1-13.4) and 0.50 mu g/L (0.30-0.79), respectively. DKA at T1D diagnosis was present in 48.4% (76/157). For eight centers with complete 2018 to 2021 data (all calendar months), no overall significant increase in T1D cases was observed during the COVID-19 pandemic, i.e. 90 cases in 2018, 90 cases in 2019, 112 in 2020 and 100 in 2021 (P for trend = 0.36). Two of the centers, Faro (CHUA) and Dona Estef & acirc;nia (CHULC) hospitals, did however see an increase in T1D from 2019 to 2020. No significant changes in glucose (P = 0.32), HbA1c (P = 0.68), fasting C-peptide (P = 0.20) or DKA frequency (P = 0.68) at the time of T1D diagnosis were observed over the entire study period.ConclusionThe T1D incidence did not increase significantly, when comparing the years before and during the COVID-19 pandemic, nor did key metabolic parameters or number of DKA episodes change.eng
dc.description.sponsorshipCENTRO-01-0145-FEDER000012-HealthyAging2020; POCI-01-0145-FEDER-007440; LA/P/0058/2020
dc.identifier.doi10.1186/s12902-024-01667-5
dc.identifier.issn1472-6823
dc.identifier.urihttp://hdl.handle.net/10400.1/26449
dc.language.isoeng
dc.peerreviewedyes
dc.publisherBioMed Central
dc.relationCenter for Innovative Biomedicine and Biotechnology
dc.relationCenter for Innovative Biomedicine and Biotechnology
dc.relation.hasversionhttps://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-024-01667-5
dc.relation.ispartofBMC Endocrine Disorders
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19
dc.subjectPortugal
dc.subjectType 1 diabetes
dc.titleAssociation between COVID-19 and the incidence of type 1 diabetes in Portugal – a registry studyeng
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleCenter for Innovative Biomedicine and Biotechnology
oaire.awardTitleCenter for Innovative Biomedicine and Biotechnology
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04539%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04539%2F2020/PT
oaire.citation.endPage10
oaire.citation.issue1
oaire.citation.startPage145
oaire.citation.titleBMC Endocrine Disorders
oaire.citation.volume24
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
relation.isProjectOfPublication428f397e-22dd-493a-b097-988a1717f76f
relation.isProjectOfPublication76a995f7-ba64-4ff6-956d-13e4b12d8234
relation.isProjectOfPublication.latestForDiscovery428f397e-22dd-493a-b097-988a1717f76f

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Association between COVID-19 and the incidence of type 1 diabetes in Portugal.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.46 KB
Format:
Item-specific license agreed upon to submission
Description: